Microbix Biosystems Inc. (TSX:MBX)

Microbix Biosystems Income Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Revenue	16.76	18.59	25.39	16.51	19.08	18.59
Revenue Growth (YoY)	-27.22%	-26.81%	53.77%	-13.43%	2.60%	76.66%
Cost of Revenue	8.93	8.73	10	9.03	7.95	7.55
Gross Profit	7.83	9.85	15.39	7.48	11.12	11.04
Selling, General & Admin	11.35	9.1	9.37	8.17	6.72	5.17
Research & Development	2.29	2.33	2.13	2.05	1.8	1.03
Other Operating Expenses	0.16	0.13	-0.01	3.08	-	-
Total Operating Expenses	13.79	11.56	11.49	13.3	8.51	6.21
Operating Income	-5.96	-1.71	3.91	-5.82	2.61	4.84
Total Non-Operating Income (Expense)	0.66	0.6	0.23	0.38	0.74	1.09
Pretax Income	-5.3	-1.11	4.14	-5.43	3.35	5.92
Provision for Income Taxes	-0.06	-0.06	0.15	-	0.08	-
Net Income	-4.27	-2.25	3.52	-0.04	1.79	3.23
Net Income to Common	-4.27	-2.25	3.52	-0.04	1.79	3.23
Net Income Growth	-	-	-	-	-44.68%	-
Shares Outstanding (Basic)	139	139	138	138	135	115
Shares Outstanding (Diluted)	139	139	138	138	142	142
Shares Change (YoY)	0.65%	0.48%	0.42%	-2.67%	0.00%	26.40%
EPS (Basic)	-0.03	-0.02	0.03	-	0.01	0.03
EPS (Diluted)	-0.03	-0.02	0.03	-	0.01	0.03
EPS Growth	-	-	-	-	-50.00%	-
Free Cash Flow	-4.24	-0.88	2.71	-2.11	1.44	0.86
Free Cash Flow Growth	-	-	-	-	66.64%	-
Free Cash Flow Per Share	-0.03	-0.01	0.02	-0.02	0.01	0.01
Gross Margin	46.74%	53.02%	60.61%	45.30%	58.32%	59.40%
Operating Margin	-35.56%	-9.18%	15.38%	-35.21%	13.68%	26.01%
Profit Margin	-25.48%	-12.08%	13.86%	-0.24%	9.38%	17.39%
FCF Margin	-25.30%	-4.72%	10.68%	-12.78%	7.55%	4.65%
EBITDA	-4.16	0.07	5.52	-4.66	3.65	5.66
EBITDA Margin	-24.82%	0.40%	21.73%	-28.20%	19.12%	30.43%
EBIT	-5.96	-1.71	3.91	-5.82	2.61	4.84
EBIT Margin	-35.56%	-9.18%	15.38%	-35.21%	13.68%	26.01%
Effective Tax Rate	1.05%	5.02%	3.64%	0.00%	2.30%	0.00%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.